Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4634-4641

  Sanada, Mitsuhiro ^a   Higashi, Yukihito ^a   Nakagawa, Keigo ^a   Tsuda, Mikio ^a   Kodama, Ichiro ^a   Kimura, Masashi ^a   Chayama, Kazuaki ^a   Ohama, Koso ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRITE;

ADULT; ARTERY RESISTANCE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; FOREARM BLOOD FLOW; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; PLETHYSMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ARTERIES; BLOOD FLOW VELOCITY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; FOREARM; HUMANS; HYPERCHOLESTEROLEMIA; HYPEREMIA; LIPIDS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NITRATES; NITRITES; NITROGLYCERIN; PEPTIDYL-DIPEPTIDASE A; PLETHYSMOGRAPHY; POSTMENOPAUSE; VASCULAR RESISTANCE;

EQUIDAE;

EID: 0036775169     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-011223     Document Type: Article

References (46)

1. Kannel WB, Hjortland MC, McNamara PM, Gordon T 1976 Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 85:447-452
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 325:756-762
3. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL 1992 Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
4. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Ronsner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE 1997 Postmenopausal hormone therapy and mortality. N Engl J Med 336:1769-1775
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
6. Sack MN, Rader JR, Cannon III RO 1994 Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269-270
7. Fischer GM, Swain ML 1997 Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Physiol 232:H617-H621
8. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
9. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA 1995 17 β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92:24-30
10. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA 1994 Estrogen improves endothelium-dependent vasodilation in postmenopausal women. Ann Intern Med 121:936-941
11. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, Ganz P, Creager MA 1998 Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 98:1158-1163
12. Kannel WB, Castelli WP, Gordon T, McNamara PM 1971 Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham Study. Ann Intern Med 74:1-12
13. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 333:1350-1351
14. Casino PR, Crescence MK, Quyyumi AA, Hoeg JM, Panza JA 1993 The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88:2541-2547
15. Stevenson JC, Crook D, Godsland IF 1993 Influence of age and menopause on serum lipid and lipoproteins in healthy women. Atherosclerosis 98:83-90
16. Campos H, McNamara SR, Wilson PWF, Ordovas JM, Schaefer EJ 1988 Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 67:30-35
17. Sanada M, Nakagawa H, Kodama I, Sakashita T, Ohama K 2000 Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia. Metabolism 49:784-789
18. Anonymous 1997 Investigating committee of guidelines for diagnosis and treatment of hyperlipidemias. J Jpn Atheroscler Soc 25:1-34
19. Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE 1990 Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22-27
20. Higashi Y, Sasaki S, Kurisu N, Yoshimizu A, Sasaki N, Matsuura H, Kajiyama G, Oshima T 1999 Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: Role of endothelium-derived nitric oxide. Circulation 100:1194-1202
21. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low density lipoprotein cholesterol in plasma without use the preparative ultracentrifuge. Clin Chem 18:499-502
22. 15N nitrate in biological fluids. Anal Biochem 126:131-138
23. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL 1999 Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905
24. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone Jr MA, Shin WS, Liao JK 1995 Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68
25. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ 1981 Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57:946-955
26. Ohara Y, Peterson TE, Harrison DG 1993 Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551
27. Evans TG, Ramussen K, Wiebke G, Hibbs Jr JB 1994 Nitric oxide synthesis in patients with advanced HIV infection. Clin Exp Immunol 97:83-86
28. Mastumoto A, Hirata Y, Momomura S, Fujita H, Yao A, Sata M, Serizawa T 1994 Increased nitric oxide production during exercise. Lancet 343:849-850
29. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
30. Tan E, Gurjar MV, Sharma RV, Bhalla RC 1999 Estrogen receptor-α gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res 43:788-797
31. Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K 2001 Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity. Atherosclerosis 158:391-397
32. Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Tsuda M, Nagai N, Ohama K 2001 Relationship between angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women. J Am Coll Cardiol 37:1529-1535
33. Proudler AJ, Ahmed AH, Crook D, Fogelman I, Rymer JM, Stevenson JC 1995 Hormone replacement therapy and serum angiotensin-corverting-enzyme activity in postmenopausal women. Lancet 346:89-90
34. Sumino H, Ichikawa S, Kanda T, Sakamaki T, Nakamura T, Sato K, Kobayashi I, Nagai R 1999 Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin. Am J Hypertens 12:1044-1047
35. Daemen MJAP, Lombardi DM, Bosman FT, Schwarts SM 1991 Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68:450-456
36. Miller VM, Vanhoutte PM 1988 Enhanced release of endothelium-derived factors by chronic increases in blood flow. Am J Physiol 255:H446-H451
37. John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE 1998 Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: A randomized, placebo-controlled, double-blind study. Circulation 98:211-216
38. Treasure CB, Klein JL, Weintraub WS, Talley D, Stillabower ME, Konsinski A, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW 1995 Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332:481-487
39. Ohara Y, Peterson TE, Sayegh HS, Harrison DG 1993 Dietary treatment of hypercholesterolemia normalizes endothelial superoxide anion production. Circulation 88 (Suppl 1):1-467
40. Chin JH, Azhar S, Hoffman BB 1994 Inactivation of endothelial-derived relaxing factor by oxidized lipoproteins. J Clin Invest 334:160-162
41. Writing Group for the PEPI Trial 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273:199-208
42. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M 1993 Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069-1075
43. Barrett-Connor EL, Wingard DL, Criqui MH 1989 Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif, revisited. JAMA 261:2095-2100
44. Modena MG, Molinari R, Muia Jr N, Castelli A, Pala F, Rossi R 1999 Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women. Am J Hypertens 12:1000-1008
45. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T 2001 A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol 87:121-125
46. Simon BC, Cunningham LD, Cohen RA 1990 Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86:75-79